Advancements in the use of gene therapy for cardiac arrhythmia.
作者信息
Murphy Nathaniel P, Lubbers Ellen R, Mohler Peter J
机构信息
Department of Physiology & Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio; Department of Internal Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Department of Physiology & Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio; Department of Internal Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio.
出版信息
Heart Rhythm. 2017 Jul;14(7):1061-1062. doi: 10.1016/j.hrthm.2017.03.041. Epub 2017 Apr 4.
Abstract
摘要
相似文献
1
Advancements in the use of gene therapy for cardiac arrhythmia.基因治疗在心律失常治疗中的进展。
Heart Rhythm. 2017 Jul;14(7):1061-1062. doi: 10.1016/j.hrthm.2017.03.041. Epub 2017 Apr 4.
2
[THERAPY OF CARDIAC ARRHYTHMIA].[心律失常的治疗]
Duodecim. 1965;81:166-78.
3
Drug therapy of cardiac arrhythmia.心律失常的药物治疗。
J La State Med Soc. 1958 Sep;110(9):299-305.
4
[Present treatment of cardiac arrhythmia. II. Selected drugs and their use according to the type of arrhythmia].[心律失常的当前治疗。II. 选定的药物及其根据心律失常类型的使用方法]
Rev Clin Esp. 1955 Jan 31;56(2):127-34.
5
[TREATMENT OF CARDIAC ARRHYTHMIA].[心律失常的治疗]
Tidsskr Nor Laegeforen. 1965 Mar 15;85:552-3.
6
[Present treatment of cardiac arrhythmia. I. Drugs].[心律失常的当前治疗。I. 药物]
Rev Clin Esp. 1955 Jan 15;56(1):45-51; contd.
7
Cardiac arrhythmia.心律失常
Am Pract Dig Treat. 1948 Dec;3(4):245-50.
8
[Cardiac arrhythmia].[心律失常]
Sem Med. 1956 Sep 27;109(15):638-42.
9
[Cardiac arrhythmia, its etiology and therapy].
Med Arh. 1962 Jan-Feb;16:127-36.
10
Cardiac arrhythmia and cardiac death.心律失常与心源性死亡。
Med Clin North Am. 1958 Jul;42(4):881-93. doi: 10.1016/s0025-7125(16)34239-0.
本文引用的文献
1
Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models.病毒介导的基因治疗治疗儿茶酚胺多形性室性心动过速（CPVT2）的小鼠模型。
Heart Rhythm. 2017 Jul;14(7):1053-1060. doi: 10.1016/j.hrthm.2017.03.025. Epub 2017 Mar 20.
2
The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.氟卡尼在儿茶酚胺能多形性室性心动过速治疗中的作用
Arrhythm Electrophysiol Rev. 2016 May;5(1):45-9. doi: 10.15420/aer.2016.3.3.
3
Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺能多形性室性心动过速
Circ J. 2016 May 25;80(6):1285-91. doi: 10.1253/circj.CJ-16-0326. Epub 2016 May 13.
4
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺能多形性室性心动过速的临床挑战
Heart Lung Circ. 2016 Aug;25(8):777-83. doi: 10.1016/j.hlc.2016.01.012. Epub 2016 Feb 16.
5
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.对于某些对β受体阻滞剂不耐受的儿茶酚胺能多形性室性心动过速患者，氟卡尼单药治疗是一种选择。
Heart Rhythm. 2016 Feb;13(2):609-13. doi: 10.1016/j.hrthm.2015.09.027. Epub 2015 Sep 28.
6
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).2015年欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防指南：欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防特别工作组。认可机构：欧洲儿科和先天性心脏病协会（AEPC）。
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.
7
Gene therapy to treat cardiac arrhythmias.基因治疗心律失常。
Nat Rev Cardiol. 2015 Sep;12(9):531-46. doi: 10.1038/nrcardio.2015.61. Epub 2015 Apr 28.
8
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age.单次腺相关病毒载体传递 CASQ2 基因转染嵌合小鼠能够从出生到老年治愈儿茶酚胺多形性室性心动过速。
Circulation. 2014 Jun 24;129(25):2673-81. doi: 10.1161/CIRCULATIONAHA.113.006901. Epub 2014 Jun 2.
9
Gene therapy for restoring heart rhythm.用于恢复心律的基因疗法。
J Cardiovasc Pharmacol Ther. 2014 Sep;19(5):426-38. doi: 10.1177/1074248414528575. Epub 2014 Apr 17.
10
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.执行摘要：HRS/EHRA/APHRS关于遗传性原发性心律失常综合征患者诊断与管理的专家共识声明。
Europace. 2013 Oct;15(10):1389-406. doi: 10.1093/europace/eut272. Epub 2013 Aug 30.
Zotero 插件